COVID-19疫苗接种触发的FDG PET/CT放射性回忆性肺炎
一名67岁转移性肺腺癌男性,接受全脑放疗、化疗及帕博利珠单抗治疗,右肺原发灶活检证实残留腺癌后行放疗(6000 cGy分15次)。放疗后18个月接种2剂mRNA COVID-19疫苗,第二剂后4天FDG PET/CT显示FDG高摄取多站淋巴结病和放射性回忆性肺炎,可能为疫苗诱发并模仿复发,未经治疗自行消退。
要点
- 放疗后18个月接种mRNA COVID-19疫苗,第二剂后4天FDG PET/CT出现放射性回忆性肺炎。
- FDG PET/CT同时显示FDG高摄取多站淋巴结病,模仿复发。
- 放射性回忆性肺炎未经治疗自行消退。
核心结论
- FDG PET/CT显示的第二剂mRNA COVID-19疫苗后放射性回忆性肺炎可能为疫苗诱发,并模仿复发,未经治疗自行消退。
研究设计与样本
- 本文为病例报告,描述一名67岁转移性肺腺癌男性患者的临床过程与FDG PET/CT表现。
主要发现
- 患者右肺原发灶活检证实残留腺癌后接受放疗(6000 cGy分15次),随访FDG PET/CT显示放射性纤维化。
- 放疗后18个月接种2剂mRNA COVID-19疫苗,第二剂后4天FDG PET/CT显示FDG高摄取多站淋巴结病和放射性回忆性肺炎。
- 放射性回忆性肺炎未经治疗自行消退。
关键数值与推荐
- 放疗剂量为6000 cGy分15次。
- FDG PET/CT在第二剂mRNA COVID-19疫苗后4天进行。
- 放射性回忆性肺炎未经治疗自行消退。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A 67-year-old man with metastatic lung adenocarcinoma was initially treated with whole-brain radiotherapy for intracranial metastases, followed by chemotherapy and pembrolizumab. After completing 2 years of systemic therapy, the primary right lung lesion was biopsy-proven to have residual adenocarcinoma, which was then treated with radiation (6000 cGy in 15 fractions). Follow-up serial FDG PET/CT showed radiation fibrosis. Eighteen months after radiotherapy, the patient received 2 doses of an mRNA COVID-19 vaccine. FDG PET/CT performed 4 days following his second vaccine dose showed FDG-avid multistation lymphadenopathy and radiation recall pneumonitis, likely vaccination-induced and mimicking recurrent disease. This resolved spontaneously without therapy.
引用
- Hughes NM, Hammer MM, Awad MM, et al. Radiation Recall Pneumonitis on FDG PET/CT Triggered by COVID-19 Vaccination. Clin Nucl Med. 2022. PMID: 34739397. doi:10.1097/RLU.0000000000003980
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。